Tijana Ignjatovic

Tijana Ignjatovic currently serves as the Executive Director for Global Market Access & Pricing at Genesis Research Group since January 2024. Previously, Tijana held various positions at Market Access Transformation between May 2019 and January 2024, including Director Ops – New Product Development Lead and Associate Director. Tijana's earlier experience includes a role as Senior Director of Trends and Market Access at Datamonitor Healthcare, where Tijana managed a team focusing on market access strategies and biosimilars analysis from May 2007 to May 2019. Additional roles include Postdoctoral Research Associate at the Brain Repair Centre, University of Cambridge, and Founder and Chief Operating Officer of Cambridge Cell Networks. Tijana's academic qualifications include a PhD in Biochemistry and Structural Biology from the University of Cambridge and a Postgraduate Certificate in International HTA from the University of Sheffield.